Terms: = Lung cancer AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA AND Prognosis
3 results:
1. Anti-hvem mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human hvem and BTLA molecules challenged with hvem expressing tumors.
Demerlé C; Gorvel L; Mello M; Pastor S; Degos C; Zarubica A; Angelis F; Fiore F; Nunes JA; Malissen B; Greillier L; Guittard G; Luche H; Barlesi F; Olive D
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37230538
[TBL] [Abstract] [Full Text] [Related]
2. A multidimensional pan-cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma.
Wei S; Lu K; Xing J; Yu W
FASEB J; 2023 Apr; 37(4):e22849. PubMed ID: 36884358
[TBL] [Abstract] [Full Text] [Related]
3. Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2.
Fang F; Zheng Q; Zhang J; Dong B; Zhu S; Huang X; Wang Y; Zhao B; Li S; Xiong H; Chen J; Wu N; Song SW; Chang C; Yang Y
Oncol Rep; 2013 Jan; 29(1):297-305. PubMed ID: 23129017
[TBL] [Abstract] [Full Text] [Related]
